Protein kinase CK2 – A key suppressor of apoptosis
- 1 January 2008
- journal article
- review article
- Published by Elsevier in Advances in Enzyme Regulation
- Vol. 48 (1), 179-187
- https://doi.org/10.1016/j.advenzreg.2008.04.002
Abstract
No abstract availableKeywords
This publication has 92 references indexed in Scilit:
- Pharmacological inhibition of protein kinase CK2 reverts the multidrug resistance phenotype of a CEM cell line characterized by high CK2 levelOncogene, 2007
- Casein kinase 2 (CK2) increases survivin expression via enhanced β-catenin–T cell factor/lymphoid enhancer binding factor-dependent transcriptionProceedings of the National Academy of Sciences, 2006
- Protein Kinase Casein Kinase 2 Mediates Inhibitor-κB Kinase and Aberrant Nuclear Factor-κB Activation by Serum Factor(s) in Head and Neck Squamous Carcinoma CellsCancer Research, 2006
- Protein kinase CK2 phosphorylates and upregulates Akt/PKBCell Death & Differentiation, 2005
- Antitumor Effect of a Novel Proapoptotic Peptide that Impairs the Phosphorylation by the Protein Kinase 2 (Casein Kinase 2)Cancer Research, 2004
- Phosphorylation of the PTEN Tail Acts as an Inhibitory Switch by Preventing Its Recruitment into a Protein ComplexJournal of Biological Chemistry, 2001
- Targeting of the transcription factor Max during apoptosis: phosphorylation-regulated cleavage by caspase-5 at an unusual glutamic acid residue in position P1Biochemical Journal, 2001
- A Potential Role of Nuclear Matrix-associated Protein Kinase CK2 in Protection against Drug-induced Apoptosis in Cancer CellsJournal of Biological Chemistry, 2001
- The Regulatory β Subunit of Protein Kinase CK2 Mediates Formation of Tetrameric CK2 ComplexesPublished by Elsevier ,2000
- Mechanism of protein kinase CK2 association with nuclear matrix: Role of disulfide bond formationJournal of Cellular Biochemistry, 1998